Abstract
Drug susceptibility testing (DST) of rapidly growing mycobacteria (RGM) are recommended for guiding the antimicrobial therapy. We have evaluated the use of resazurin in Mueller–Hinton medium (MHR) for MIC determination of RGM and compared the results with those obtained with the reference standard broth microdilution in Mueller–Hinton (MH) and with the resazurin microtiter assay (REMA) in 7H9 broth. The MIC of eight drugs: amikacin (AMI), cefoxitin (FOX), ciprofloxacin (CIP), clarithromycin (CLA), doxycycline (DOX), linezolid (LZD), moxifloxacin (MXF) and trimethoprim-sulfamethoxazole (TMP-SMX) were evaluated against 76 RGM (18 species) using three methods (MH, MHR, and REMA) in a 96-well plate format incubated at 37 °C over 3–5 days. Results obtained in the MH plates were interpreted by the appearance of turbidity at the bottom of the well before adding the resazurin. MHR and 7H9-REMA plates were read by visual observation for a change in color from blue to pink. The majority of results were obtained at day 5 for MH and 1 day after for MHR and 7H9-REMA. However, the preliminary experiment on time to positivity results using the reference strain showed that the resazurin can be added to the MH at day 2 to produce the results at day 3, but future studies with large sets of strains are required to confirm this suggestion. A high level of agreement (kappa 1.000–0.884) was obtained between the MH and the MHR. Comparison of results obtained with 7H9-REMA, on the other hand, revealed several discrepancies and a lower level of agreement (kappa 1.000–0.111). The majority of the strains were resistant to DOX and TMP-SMX, and the most active antimicrobials for RGM were AMI and FOX. In the present study, MHR represented an excellent alternative for MIC determination of RGM. The results could be read reliably, more easily, and more quickly than with the classical MH method.
Similar content being viewed by others
References
Falkinham JO III (2009) Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J Appl Microbiol 107:356–367
Set R, Shastri J (2011) Laboratory aspects of clinically significant rapidly growing mycobacteria. Indian J Med Microbiol 29:343–352
Yu JR, Heo ST, Lee KH, Kim J, Sung JK, Kim YR, Kim JW (2013) Skin and soft tissue infection due to rapidly growing mycobacteria: case series and literature review. Infect Chemother 45:85–93
El Helou G, Viola GM, Hachem R, Han XY, Raad II (2013) Rapidly growing mycobacterial bloodstream infections. Lancet Infect Dis 13:166–174
Yano Y, Kitada S, Mori M, Kagami S, Taguri T, Uenami T, Namba Y, Yoneda T, Yokota S, Maekura R (2013) Pulmonary disease caused by rapidly growing mycobacteria: a retrospective study of 44 cases in Japan. Respiration 85:305–311
Hsiao CH, Tsai TF, Hsueh PR (2011) Characteristics of skin and soft tissue infection caused by non-tuberculous mycobacteria in Taiwan. Int J Tuberc Lung Dis 15:811–817
Brown-Elliott BA, Nash KA, Wallace RJ Jr (2012) Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev 25:545–582
Van Ingen J, Boeree MJ, van Soolingen D, Mouton JW (2012) Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resist Updat 15:149–161
Cardoso AM, Junqueira-Kipnis AP, Kipnis A (2011) In vitro antimicrobial susceptibility of Mycobacterium massiliense recovered from wound samples of patients submitted to arthroscopic and laparoscopic surgeries. Minim Invasive Surg 2011:724635
Clinical and Laboratory Standards Institute (2011) Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard, 2nd edn. CLSI document M24-A2
Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F (2002) Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 46:2720–2722
Martin A, Camacho M, Portaels F, Palomino JC (2003) Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother 47:3616–3619
Broda A, Jebbari H, Beaton K, Mitchell S, Drobniewski F (2013) Comparative drug resistance of Mycobacterium abscessus and M. chelonae isolates from patients with and without cystic fibrosis in the United Kingdom. J Clin Microbiol 51:217–223
Collins LA, Franzblau SG (1997) Microplate alamar blue verses BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 41:1004–1009
Vanitha JD, Paramasivan CN (2004) Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates. Diagn Microbiol Infect Dis 49:179–182
Li G, Lian L, Wan L, Zhang J, Zhao X, Jiang Y, Zhao L, Liu H, Wan K (2013) Antimicrobial susceptibility of standard strains of nontuberculous mycobacteria by microplate alamar blue assay. PLoS One 88:e84065
Jadaun GP, Agarwal C, Sharma H, Ahmed Z, Upadhyay P, Faujdar J, Gupta AK, Das R, Gupta P, Chauhan DS, Sharma VD, Katoch VM (2007) Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay. J Antimicrob Chemother 60:152–155
Cavusoglu C, Gurpinar T, Ecemis T (2012) Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel. New Microbiol 35:73–76
Wallace RJ Jr, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW (2002) Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 46:3164–3167
Huang YC, Liu MF, Shen GH, Lin CF, Kao CC, Liu PY, Shi ZY (2010) Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing. J Microbiol Immunol Infect 43:401–406
Reddy AK, Garg P, Babu KH, Gopinathan U, Sharma S (2010) In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis. Curr Eye Res 35:225–229
Gayathri R, Therese KL, Deepa P, Mangai S, Madhavan HN (2010) Antibiotic susceptibility pattern of rapidly growing mycobacteria. J Postgrad Med 56:76–78
Gitti Z, Mantadakis E, Maraki S, Samonis G (2011) Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece. Future Microbiol 6:1099–1109
Acknowledgements
We thank Dr. Edward Moore for kindly providing us with CCUG type and reference strains. We acknowledge the “Coordenação de Aperfeiçoamento de Pessoal de Nível Superior” (CAPES, Brazil) for the financial support to Ivy Bastos Ramis (PDSE-7675/13-5).
Conflict of interest
The authors declare that they have no conflicts of interest.
Compliance with ethical standards
We confirm that no human participants or animals were included in this study. Consequently, no informed consent was needed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramis, I.B., Cnockaert, M., von Groll, A. et al. Antimicrobial susceptibility of rapidly growing mycobacteria using the rapid colorimetric method. Eur J Clin Microbiol Infect Dis 34, 1403–1413 (2015). https://doi.org/10.1007/s10096-015-2365-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-015-2365-2